Research Site

Sabak Bernam 88996

1 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Carcinoma, Gastroesophageal Junction Adenocarcinoma, HER2-positive Gastric Cancer, Non-Small-Cell Lung, Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck

Studies at this site

• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy — Recruiting now
• A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer — Recruiting now
• Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment — Running, not enrolling
• Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck — Completed